DrugPatentWatch Database Preview
PACERONE Drug Profile
» See Plans and Pricing
When do Pacerone patents expire, and what generic alternatives are available?
Pacerone is a drug marketed by Upsher Smith Labs and is included in one NDA.
The generic ingredient in PACERONE is amiodarone hydrochloride. There are fifteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the amiodarone hydrochloride profile page.
US ANDA Litigation and Generic Entry Outlook for Pacerone
A generic version of PACERONE was approved as amiodarone hydrochloride by TEVA PHARMS on November 30th, 1998.
Summary for PACERONE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 3 |
| Bulk Api Vendors: | 48 |
| Clinical Trials: | 8 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for PACERONE |
| Drug Sales Revenues: | Drug sales revenues for PACERONE |
| DailyMed Link: | PACERONE at DailyMed |
US Patents and Regulatory Information for PACERONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Upsher Smith Labs | PACERONE | amiodarone hydrochloride | TABLET;ORAL | 075135-002 | Apr 12, 2005 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Upsher Smith Labs | PACERONE | amiodarone hydrochloride | TABLET;ORAL | 075135-001 | Apr 30, 1998 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
